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Opinion statement
Electronic chromoendoscopy (EC) is an equipment-based technology which could be easily
activated by push of a button. There are four EC techniques available for use at present:
narrow band imaging (NBI), i-Scan, flexible spectral chromoendoscopy and blue laser
imaging. Out of the four techniques, NBI has been extensively evaluated for the detection
and characterization of dysplasia in colonic polyps and dysplasia associated with inflam-
matory bowel disease. In this review, we will focus on the new developments and
applications of EC.
Introduction
Colorectal cancer (CRC) is one of the commonest
causes of significant morbidity and mortality in
the western world. It is the second most common
cause of cancer-related mortality in Europe and
the fourth most common cause worldwide [1].
Sporadic CRC arises from adenomatous polyps in
a well described adenoma-carcinoma sequence [2].
Approximately, 15–30 % of CRC arise via serrated
pathway from precursor lesions and serrated ade-
nomas [3]. Familial CRC and CRC associated with
inflammatory bowel disease also arise from dys-
plastic lesions which can be detected at colonos-
copy.
Colonoscopy is the most valuable weapon in
the fight against CRC. The efficiency of CRC pre-
vention with colonoscopy depends on complete
and careful inspection of colonic mucosa for dys-
plastic lesions and their successful removal before
they progress to cancer [4]. Various techniques
have been developed to improve the detection
and characterization of dysplastic lesions including
chromoendoscopy, electronic chromoendoscopy
and autofluorescence [5•, 6•].
Electronic chromoendoscopy (EC) refers to endo-
scopic imaging technologies which provide detailed
contrast enhancement of the mucosal surface and blood
vessels. They provide an alternative to conventional
chromoendoscopy and improve mucosal visualization
of surface and vascular structures through the use of
optical filters or software-driven post-image processing
[6•, 7]. EC technologies include narrow band imaging
(NBI) (Olympus Medical Co., Tokyo, Japan), flexible
spectral imaging colour enhancement (FICE) (Fujinon,
Fujifilm Co., Saitama, Japan), i-Scan (Pentax Endosco-
py, Tokyo, Japan) and blue laser imaging (BLI) (Fujinon,
Fujifilm Co., Saitama, Japan).
NBI is an endoscopic optical image enhancement
technology. It is based on the penetration properties of
light, which is directly proportionate to wavelength.
Because most of the NBI light is absorbed by the blood
vessels in the mucosa, the resulting image emphasizes
the blood vessels in sharp contrast with the non-vascular
structures in the mucosa. FICE is a digital imaging post-
processing technique, in which white light endoscopic
images from the video processor are altered to display a
composite colour-enhanced image in real time. i-Scan
(Penatax) is similarly a software-based digital, post-
processing image enhancement technology. It provides
enhanced images of the mucosal surface and the blood
vessels through post-image processing. i-Scan enhances
contrast and thereby mucosal surface detail including
enhanced mucosal surface texture and sharpened views
of surface vessels, thereby improving the visibility of
blood vessels [6•].
NBI is the most extensively evaluated EC technique
in patients undergoing screening or surveillance colo-
noscopy.
In this review, we focus on the latest developments in
the field of electronic chromoendoscopy during colo-
noscopy, applications and future directions.
Electronic chromoendoscopy and detection of dysplasia
Adenoma detection
Adenoma detection rate (ADR) is one of the key quality indicators of colonos-
copy and has been shown to inversely correlate with post-colonoscopy interval
cancers [8].
NBI
NBI is the most extensively evaluated EC modality in terms of adenoma
detection. Multiple randomized controlled trials showed there was no signifi-
cant difference in adenoma detection of NBI when compared to white light
endoscopy (WLE). East and colleagues randomized 214 patients to examina-
tion with NBI or WLE [9]. They showed there was no significant difference in
ADR betweenNBI andWLE (OR 1.4, 95%CI 1.52–4.63, p=0.26). However the
detection of flat adenomas were significantly better with NBI (CR 1.92, 95 % CI
1.07–3.44, p=0.003) [9]. Similar results were described in the study performed
by Ikematsu et al. [10] in a multicentre, tandem study that randomized 813
patients to undergo either NBI followed byWLE or WLE followed by NBI. They
detected no significant difference in ADR (42.3 % for NBI and 42.5 %
for WLE).
Meta-analyses comparing WLE and NBI for the detection of adeno-
mas are summarized in Table 1 [11–15]. Overall, the superiority of NBI
over WLE for adenoma detection is not universal and not convincing.
One meta-analysis showed that NBI performed better in detecting flat
adenomas (RR 1.96, 95 % CI 1.09–3.52, p=0.02) [11].
A recent study comparing new-generation NBI (Olympus Exera
HQ190) and high-definition (HD) WLE in a randomized trial with
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tandem colonoscopy showed encouraging results for NBI [16••]. ADR
were significantly better in the NBI group when compared to WLE (48.3
and 34.4 %, p=0.01). Similarly, polyp detection rate was better with
NBI (61.1 and 48.3 %, p=0.02).
Sessile serrated lesions
These polyps could be easily missed due to the subtle appearance (pale colour,
poorly defined edges and the presence of mucus on the surface) [17••]. There-
fore, endoscopists need to spend additional time to carefully examine the
mucosa for sessile serrated adenomas/polyps (SSA/P) especially in the
right colon.
NBI has the potential to improve the detection of subtle lesions.
Recently, Rex and colleagues performed a randomized controlled trial
involving 804 patients to determine the impact of new-generation NBI
(Olympus 190 series) to detect SSA/P [18••]. Although numerically
more SSA/P proximal to the sigmoid colon of any size were detected in
NBI group when compared to WLE group (204 and 158, p=0.085), this
was not statistically significant.
FICE
There is limited data available on the use of FICE. Two prospective, random-
ized, controlled trials that compared FICE with WLE failed to show any im-
provement in polyp detection or adenoma detection. Aminalai et al. recruited
637 patients into each group [19]. There was no difference in polyp detection
(31.9 % with FICE and 27.7 % with WLE, p=0.10) or ADR (28 % each,
p=0.95). The second trial performed by Pohl et al. involving 764 patients did
not demonstrate an improvement in adenoma detection with FICE compared
to WLE (236 and 271, p=0.92) [20]. A randomized, tandem study in average-
risk patients undergoing screening colonoscopy comparedWLE with either NBI
or FICE [21]. Chung et al. recruited 1650 subjects (550 in each group). FICE did
not show any increment in ADR when compared with WLE or NBI (25.3 and
24.5 %, p=0.75). Similarly, a meta-analysis conducted by Omata and col-
leagues, comparing FICE/i-Scan showed no benefit overWLE (RR 1.09, 95%CI
0.97–1.23) [15].
i-Scan
The studies using i-Scan in the detection of adenomas showed mixed results.
Hoffmann et al. highlighted a superior ADR with i-Scan when compared to
Table 1. Meta-analysis comparing NBI and WLE
Author Year of publication No. of studies Total no. of patients ADR
Jin et al. [11] 2011 08 3049 RR 1.09 (95 % CI 1.00–1.19)
Dinesen et al. [12] 2012 07 2936 RR 1.06 ( 95 % CI 0.92–1.16)
Nagorni et al. [13] 2012 08 3673 RR 0.94 (95 % CI 0.87–1.02)
Pasha et al. [14] 2012 09 3059 OR 1.01 (95 % CI 0.74–1.37)
Omata et al. [15] 2014 14 5074 RR 1.03 (95 % CI 0.96–1.11)
RR relative ratio, OR odds ratio, CI confidence interval
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WLE (38 and 13%, pG0.0001). The detection rate for flat adenomas was higher
with i-Scan compared toWLE (58 and 23%, pG0.0001) [22]. However, the very
low ADR in the white light group in this study may have exaggerated the
potential benefit of i-SCAN. Two further prospective, tandem studies showed
conflicting results. Once again, Hoffmann et al. showed significantly low ade-
noma miss rate with i-Scan compared to WLE (30 and 62.5 %, pG0.001) [23]
whereas another back to back study demonstrated no significant difference in
ADR (36.5 and 31.9 %, p=0.54) and adenoma miss rate (19.3 and 22.9 %,
p=0.69) comparing WLE and i-Scan [24]. The largest prospective, randomized
trial comparing i-Scan with HD WLE involving 1936 patients showed promis-
ing results [25••]. Polyps and adenomas were consistently detected more
frequently in the i-Scan cohort; 56% of the i-Scan group patients had a polyp of
any type detected compared to 47% in the control group (p=0.03). Adenomas
were detected more frequently in the i-Scan group compared to the WLE group
(33 and 27%, p=0.033). Significantly, more diminutive adenomas were found
in the i-Scan group compared to the control group (40.2 and 28.0 %,
pG0.01) [25••].
BLI
To date, there is no published data available on the use of BLI to improve
adenoma detection.
In summary, EC especially NBI and i-Scan may improve the detection of
diminutive polyps. However, none of the modalities demonstrated consistent
improvement in ADR, and, therefore, the routine use of EC is not currently
recommended for routine screening or surveillance colonoscopy.
Electronic chromoendoscopy in inflammatory bowel disease
Long-standing history of ulcerative colitis and Crohn’s colitis are well recog-
nized risk factors for the development of CRC. The cancer risk increases with
extent, duration and degree of inflammation, presence of primary sclerosing
cholangitis and family history of CRC [26–28].
Therefore, regular surveillance in IBD population is recommended by all
major society guidelines (British Society of Gastroenterologists (BSG), Europe-
an Crohn’s and Colitis Organization (ECCO), European Society of Gastroin-
testinal Endoscopy (ESGE), American Gastroenterological Association (AGA))
[29–32].
European guidelines (ESGE, ECCO and BSG) recommend the routine use of
pancolonic chromoendoscopy with targeted biopsies for neoplasia surveillance
in patients with long-standing colitis [29–32]. However, chromoendoscopy
technique is unappealing as it prolongs the procedure time in addition to being
cumbersome as well as requiring sufficient expertise [33].
EC has the advantage over traditional chromoendoscopy as the image
enhancement mode can be activated by push-button technology, and it is
cheaper, quicker and more user-friendly.
Two randomized controlled trials compared high-definition (HD) NBI to
CE. In a tandem study performed by Pellise et al., patients with long-standing
colitis (n=60) were randomized with HDNBI or CE [34]. The study showed no
significant difference in dysplasia detection, and although NBI showed a nu-
merically higher miss rate for dysplastic lesions when compared to CE (13.6 vs
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31.8 %), this was not statistically significant [34]. A multicentre parallel ran-
domized study involving 108 patients with chronic colitis showed a compara-
ble detection rate for dysplastic lesions (18 with NBI and 26 with CE, p=0.385)
[35]. Efthymiou et al. performed a back to back study with HDNBI followed by
CE in patients with long-standing colitis (98 years duration) [36]. Overall, CE
detected more lesions than NBI (131 vs 103, pG0.001); however, most of them
were non-dysplastic. There was no difference in dysplasia detection—CE de-
tected 23 dysplastic lesions in 11 patients and NBI 20 lesions in 10 patients
(p=0.18). Similarly, studies comparing NBI with standard WLE failed to show
any improvement in the detection of dysplasia [37, 38].
To date, NBI has failed to show any improvement in the detection of
dysplasia in IBD when compared to WLE or CE. There are no published data
available using FICE, i-Scan and BLI in colitis surveillance.
In summary, the current evidence does not support the use of EC in sur-
veillance in IBD at present.
Polyp characterization and optical diagnosis
The current practice mandates that all small polyps detected during colonos-
copy should be resected and sent for histopathological assessment to determine
the histopathological type ( adenoma, hyperplastic or more recently serrated
lesions), as colonoscopic surveillance intervals are influenced by the number,
size and histological features of polyps (i.e. adenoma, presence of villous
features and high-grade dysplasia) [39, 40]. The majority of polyps detected at
colonoscopy are diminutive (G5 mm) and rarely harbour cancer or high-risk
features such as high-grade dysplasia or villous component [41, 42, 43••].
As diminutive polyps are of such limited significance, being able to diagnose
adenomas in vivowould allow for them to be resected and discarded, saving the
costs associated with histopathology. Furthermore, diagnosing distal hyper-
plastic polyps in vivo would allow for these to be left in situ (diagnose and
disregard) reducing the risks associated with polypectomy [43••]. Estimates
suggest that by implementing resect and discard policy savings of $33million to
$1 billion could be made annually in the USA alone [44]. Recent generation of
high-definition instruments with virtual or electronic chromoendoscopy has
enabled endoscopists to attempt to predict the histological type of polyps
in vivo.
NBI
Majority of the studies assessed NBI, a blue light optical imaging modality
which enhances the mucosal architecture, especially vasculature. Vascular den-
sity and pattern differ between neoplastic (adenoma) and non-neoplastic
(hyperplastic) polyps, allowing an endoscopist to use NBI to differentiate
between the two (Fig. 1) [45]. A group of international experts have developed
and validated a system to characterize small colonic polyps: the NBI Interna-
tional Colorectal Endoscopic (NICE) Classification (Table 2) [46]. This classi-
fication uses mucosal colour, vessel and surface pattern to differentiate between
hyperplastic polyps and adenoma (Table 2). It is applicable for non-magnified
NBI imaging. Authors made a diagnostic prediction with high confidence in
75 % of the 236 polyps (82 % in adenomas and 64 % in hyperplastic). These
diagnoses achieved accuracy of 88%, sensitivity of 98% and negative predictive
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value of 95 % for diminutive polyps [46]. A meta-analysis by Wanders and
colleagues evaluated real-time optical diagnosis by NBI and showed an overall
sensitivity 91 % (95 % CI 88.6–93.0), specificity 85.6 % (81.3–89.0) and real-
time negative predictive value 82.5 % (75.4–87.9) [47]. However, most of the
studies in themeta-analysis were carried out by expert endoscopists in academic
centres [47]. Ladabaumand colleagues prospectively evaluated real-time optical
diagnosis of polyps with NBI by community-based gastroenterologists [48].
This study showed inferior results when compared to the academic centres with
sensitivity, specificity and negative predictive values of 85, 78 and 91 %,
             Colonic polyp 
Type 2 polyp Type 1 polyp 
                 Adenoma         Sessile serrated adenoma/polyp            Hyperplastic polyp 
One of the following features: 
Brown colour? 
Brown vessels? 
Oval tubular or branched surface pattern? 




Dark spots inside crypts? 









Fig. 1. NBI images of polyps. Clockwise: NBI images of hyperplastic polyp, adenoma, adenoma, SSA/P and SSA/P.
Table 2. NICE classification
Colour Same or lighter than background Browner relative to background
Vessels None or isolated lacy vessels coursing
across the lesion
Surface pattern Dark or white spots of uniform size or
homogenous absence of pattern
Oval, tubular or branched white structures
surrounded by brown vessels
Most likely pathology Hyperplastic Adenoma
Adapted from Hewett DG, Kaltenbac T, Sano Y, et al. Validation of a simple system for endoscopic diagnosis of small colorectal polyps using NBI.
Gastroenterology 2012;143:599–607.e1; with permission
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respectively. New NBI system with near focus might offer a solution for this
discrepancy as near-focus image may provide a more detailed view of the
surface architecture. Singh et al. assessed 149 polyps using Olympus 190 series
Exera III NBI systemwith dual focus (DF) capabilities [49]. The overall accuracy
of NBI-DF when compared to final histopathology was 97%. In addition, post-
polypectomy surveillance interval when based on optical diagnosis was accu-
rate in 97% of cases with high negative predictive value (100%) for diminutive
rectosigmoid polyps.
SSA/P
It is often difficult if not impossible to differentiate hyperplastic polyps (HP)
from SSA/P on white light endoscopic examination. Yamada et al. performed a
retrospective image evaluation study in which 242 NBI lesions were evaluated
by 2 experienced endoscopists [50••]. Multivariate analysis demonstrated that
the presence ofDilated and ranching vessels (DBV) on the surface had a 2.3-fold
odds ratio (95 % CI 0.96–5.69) among SSA/P compared to HPs. When DBV,
proximal location and polyp size 910 mm were combined, the positive pre-
dictive value reached 92 % for SSA/P making it promising for the optical
diagnosis of serrated lesions. Recently, IJspeert and colleagues developed a new
classification system for in vivo differentiation of adenomas, HPs and
SSA/P; the Workgroup serrAted polypS and Polyposis (WASP) classifi-
cation (Fig. 2) [51••].
FICE
Teixeira and colleagues proposed an endoscopic classification of the superficial
capillary-vessel pattern of colorectal lesions to differentiate neoplastic polyps
form non-neoplastic polyps: types 1 and 2 are hyperplastic polyps, types 3 and
4 are adenomas and type 5 capillary pattern indicates invasive cancer [52]. The
authors analysed 309 colorectal lesions using the Teixeira capillary-vessel pat-
tern classification and found 99.2 % sensitivity and 94.9 % specificity for
neoplastic lesions [52].
Fig. 2. WASP classification. Adapted from IJspeert JE, Bastiaansen BA, van Leerdam ME, et al. Development and validation of the
WASP classification system for optical diagnosis of adenomas, hyperplastic polyps and sessile serrated adenomas/polyps. Gut
2015;0:1–8; with permission.
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Large prospective UK series by Longcroft-Wheaton et al. compared FICE
with WLE and found that FICE improved the accuracy of in vivo diagnosis of
adenoma from 75 to 88 % (pG0.001) [53]. When using FICE, endoscopists
predicted post-polypectomy surveillance interval with accuracy of 97 %. The
previously mentioned meta-analysis by Wanders et al. examined 14 studies
which used FICE to distinguish neoplastic polyps from non-neoplastic polyps
in vivo during screening colonoscopies [47]. FICE showed a sensitivity of
91.8 % and negative predictive value of 83.7 %.
i-Scan
A recent meta-analysis of 11 studies using i-Scan to differentiate neoplastic
polyps from non-neoplastic polyps, which included 925 patients with 2312
polyps, demonstrated a sensitivity of 91.5 % and specificity of 92.1 % [54].
BLI
Blue laser imaging (BLI) by Fujinon LASEREO system allows for narrow band
observation. The BLI light is useful for acquiring mucosal surface information
such as vascular and surface patterns (Fig. 3). Yoshida et al. retrospectively
examined 314 colorectal polyp images [55]. The overall diagnostic accuracy of
BLI without magnification for differentiating between neoplastic and non-
neoplastic polyps (G10 mm) was 95.2 %, which was greater than that of WLE
(83.2 %).
In summary, EC is a promising imaging technology to make an accurate
optical diagnosis in vivo. NBI has been extensively evaluated and is highly
accurate in expert hands in predicting the histopathology of small polyps. It is a
user-friendly and easy to apply technique with a push of a button. FICE and i-
Scan showed encouraging results. BLI technique needs to be explored further in
randomized controlled trials.
Implementation of optical diagnosis
The initial clinical studies suggested that optical diagnosis for diminutive
colorectal polyps could be feasible and safe in routine clinical practice. How-
ever, recent reports suggest that optical diagnosis performed by non-academic
gastroenterologists could not reproduce similar results. Therefore, certain key
steps should be followed before translating optical diagnosis into the commu-
nity practice.
Consequently, the American Society of Gastrointestinal Endoscopy (ASGE)
developed a Preservation and Incorporation of Valuable Endoscopic Innova-
tions (PIVI) statement for in vivo endoscopic assessment of diminutive polyps
[56•]. Furthermore, a recent update on ‘implementation of optical diagnosis of
colorectal polyps’ raised the issues of training, competency assessment and
Fig. 3. BLI images of polyps. Clockwise: BLI images of hyperplastic polyp, adenoma and adenoma.
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documentation before optical diagnosis could be implemented into routine
clinical practice [57].
Training and competency assessment
The knowledge and skills required to perform optical diagnosis can be
learned by people with varying experiences in colonoscopy. Ignjatovic
et al. from St Mark’s Hospital used a still image-based teaching module
to differentiate between adenomas and hyperplastic polyps [58]. They
showed improved accuracy and specificity of optical diagnosis for all
group of participants which included novices, trainees and experienced
colonoscopists after a short training module (k=0.56, 0.70 and 0.54,
respectively). Recently, WASP classification showed some promising re-
sults in differentiating HPs from SSA/P [51••]. In a still image evalua-
tion setting, the introduction of the WASP classification significantly
improved the accuracy of optical diagnosis overall and proved to be
sustainable after 6 months. Overall, the accuracy of optical diagnosis
improved from 63 % before training to 79 % after training (pG0.001)
and remained at 76 % after 6 months. This study highlighted the
importance of continued training and re-assessment of individuals who
perform optical diagnosis to maintain the threshold. The fact ex vivo
training does not necessarily translate into actual clinical practice was
highlighted by the study by Ladabaum and colleagues [48]. In an
evaluation of real-time optical diagnosis with NBI, only 25 % of gas-
troenterologists assessed polyps with ≥90 % accuracy while more than
83 % of gastroenterologists performed with 990 % accuracy ex vivo.
These findings suggest that in vivo training with feedback and as-
sessment is needed before non-academic gastroenterologists are certified
to perform optical diagnosis in routine clinical practice.
Documentation
High-quality image of the polyp assessed by optical modality should be taken
for quality assurance and medicolegal purposes. The question of whether high-
quality video clips are necessary for documentation remains to be answered.
Conclusion
The routine use of EC is becoming more popular among the western
endoscopists as an alternative to traditional chromoendoscopy due to its wider
availability and user-friendly nature. Although there is uncertainty whether NBI
improves overall adenoma detection, there are trends that suggest that it may
improve the detection of diminutive polyps and sessile serrated polyps. Fur-
thermore, NBI is superior in characterizing polyps especially sessile serrated
adenomas when compared to white light. Recent studies showed promising
results for i-Scan as well. There is an unprecedented focus on real-time predic-
tion of histology using EC. This ability would allow the endoscopists to predict
the surveillance intervals immediately after the colonoscopic examination and
could potentially lead to significant cost savings to the health care system.
However, the implementation of optical diagnosis in clinical practice needs to
be agreed by the relevant gastroenterological societies. Robust and rigorous
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training, accreditation and quality assurance aspects need to be agreed and
validated.
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